🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
IND
$INDP
🔒 US EquitiesIntec Parent Inc
AVG HISTORICAL GAP
-0.47%
MAX GAP RECORD
+6.82%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $INDP
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$INDP
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Mar 17, 2026 Earnings Release 2026-03-17 (AFTER CLOSE) |
+1.53%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN) |
+0.37%
|
| Aug 13, 2025 Earnings Release 2025-08-13 (BEFORE OPEN) |
-4.98%
|
| May 14, 2025 Earnings Release 2025-05-14 (BEFORE OPEN) |
+6.82%
|
| Mar 13, 2025 Earnings Release 2025-03-13 (BEFORE OPEN) |
-2.14%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-5.79%
|
| Aug 12, 2024 Earnings Release 2024-08-12 (BEFORE OPEN) |
+2.94%
|
| May 07, 2024 Earnings Release 2024-05-07 (BEFORE OPEN) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.4%
Bullish Gaps (4)
Bearish Gaps (7)
Neutral / Flat (1)
📖 Intelligence Summary
Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗